Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A framework for setting enrollment goals to ensure participant diversity in sponsored clinical trials in the United States.
Cullen MR, Lemeshow AR, Amaro S, Bandera EV, Cooper LA, Kawachi I, Lunyera J, McKinley L, Poss CS, Rottas MM, Schachterle SE, Thadeio PF, Russo LJ. Cullen MR, et al. Among authors: schachterle se. Contemp Clin Trials. 2023 Jun;129:107184. doi: 10.1016/j.cct.2023.107184. Epub 2023 Apr 11. Contemp Clin Trials. 2023. PMID: 37054773 Free article.
Validation of safety outcomes in routinely collected data: Lessons learned from a multinational postapproval safety study.
Arena PJ, Huang K, Löfling L, Bahmanyar S, Mo J, Schachterle SE, Nunes AP, Smits E, Juuti R, Hoti F, Korhonen P, Adelborg K, Sundbøll J, Rasmussen TR, Løkke A, Ehrenstein V. Arena PJ, et al. Among authors: schachterle se. Pharmacoepidemiol Drug Saf. 2023 May;32(5):592-596. doi: 10.1002/pds.5582. Epub 2022 Dec 29. Pharmacoepidemiol Drug Saf. 2023. PMID: 36495188 No abstract available.
Outcomes in patients with lung cancer treated with crizotinib and erlotinib in routine clinical practice: A post-authorization safety cohort study conducted in Europe and in the United States.
Ehrenstein V, Huang K, Kahlert J, Bahmanyar S, Karlsson P, Löfling L, Nunes AP, Enger C, Bezemer ID, Kuiper JG, Hoti F, Juuti R, Korhonen P, Mo J, Schachterle SE, Wilner KD, Rørth M, Sørensen HT. Ehrenstein V, et al. Among authors: schachterle se. Pharmacoepidemiol Drug Saf. 2021 Jun;30(6):758-769. doi: 10.1002/pds.5193. Epub 2021 Jan 24. Pharmacoepidemiol Drug Saf. 2021. PMID: 33428292
12 results